Crystalline (2S) -3-(3S, 4S) -3-(1R) -1-hydroxyethyl -4- (4-methoxy-3-{1- (5-methylpyridin-2-yl) ) Azetidin-3-yl oxy} phenyl) -3-methylpyrrolidin-1-yl -3-oxopropane-1,2-diol

摘要

The invention provides crystalline (2S)-3-[(3S,4S)-3-[(1R)-1-hydroxyethyl]-4-(4-methoxy-3-{[1-(5-methylpyridin-2-yl)azetidin-3-yl]oxy}phenyl)-3-methylpyrrolidin-1-yl]-3-oxopropane-1,2-diol, and pharmaceutical compositions thereof. The invention further provides methods of using this compound to treat overactive bladder.